Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACEBUTOLOL | 200MG | TABLET | Resolved | 2018-02-26 | 2019-01-22 | 41071 |
| ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-02-26 | 2019-01-22 | 41074 |
| MINOCYCLINE | 50MG | CAPSULE | Resolved | 2017-09-14 | 2019-01-22 | 22094 |
| MINOCYCLINE | 100MG | CAPSULE | Resolved | 2017-09-14 | 2019-01-22 | 22098 |
| BACLOFEN | 10MG | TABLET | Resolved | 2019-01-10 | 2019-01-25 | 71821 |
| CLARITHROMYCIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-01-07 | 2019-02-06 | 71374 |
| PROPAFENONE | 300MG | TABLET | Resolved | 2018-06-26 | 2019-02-06 | 52919 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-11-28 | 2019-02-06 | 30915 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-12-18 | 2019-02-06 | 33667 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-15 | 2019-02-13 | 72253 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-11-21 | 2019-02-13 | 67303 |
| LOSARTAN | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67324 |
| LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67315 |
| PROPAFENONE | 150MG | TABLET | Resolved | 2018-04-12 | 2019-02-20 | 45511 |
| QUETIAPINE | 100MG | TABLET | Resolved | 2019-01-15 | 2019-02-20 | 72239 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-25 | 2019-02-26 | 73517 |
| LOSARTAN | 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-26 | 67327 |
| CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72248 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72242 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-02-11 | 2019-03-02 | 75262 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |